Detalles de la búsqueda
1.
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
Circulation
; 134(24): 1918-1930, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881559
2.
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Catheter Cardiovasc Interv
; 89(7): E217-E225, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650638
3.
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database.
Catheter Cardiovasc Interv
; 87(3): 363-73, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011467
4.
Intracoronary delivery of eptifibatide with the ClearWay® RX infusion catheter.
Catheter Cardiovasc Interv
; 77(2): 222-7, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20824759
5.
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis.
J Thromb Thrombolysis
; 31(4): 493-500, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21318582
6.
Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes.
J Thromb Thrombolysis
; 30(1): 10-3, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354760
7.
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.
Nat Rev Cardiol
; 17(4): 242-257, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31953535
8.
Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation.
J Thromb Thrombolysis
; 28(3): 288-98, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19030969
9.
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.
Clin Cardiol
; 42(9): 797-805, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254472
10.
Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials.
Atherosclerosis
; 277: 211-218, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30025648
11.
A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States.
Clin Cardiol
; 37(5): 312-21, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24945038
12.
Incremental benefit of 80-lead electrocardiogram body surface mapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST-elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myocardial Infarction (OCCULT MI) trial.
Acad Emerg Med
; 17(9): 932-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20836773
13.
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies.
Eur Heart J
; 25(13): 1139-45, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15231372
Resultados
1 -
13
de 13
1
Próxima >
>>